Delivery Order SPE2DB25D3005-SPE2DB25FQFKE
Award Date 5/22/25
Potential Completion Date 5/23/25
Potential Value $4.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 1, 2025, for the supply of HUMIRA Pen 40 mg/0.8 mL, a biologic medication used to treat inflammatory conditions. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,079.62 and is scheduled for completion by July 2, 2025. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for HUMIRA Pen 40 mg/0.8 mL, a biologic medication used to treat autoimmune conditions. The contract, valued at $2,265.90, was awarded on September 9, 2025, with an ultimate completion date of September 10, 2025. This is a firm fixed-price delivery order issued under a non-set-aside procurement, reflecting open competition. The place of performance is listed as AmerisourceBergen's corporate office...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, an injectable pharmaceutical product used to treat autoimmune conditions. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,510.60 and is scheduled for completion by September 3, 2025. The contract represents a child order under DLA's broader pharmaceutical procurement framework, with the place...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on April 21, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a prescription immunosuppressant medication used to treat autoimmune diseases. This firm fixed-price delivery order, valued at $25,463.41, represents a non-competitive set-aside award with an ultimate completion date of April 22, 2025, and will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. The award...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL with a firm fixed price ceiling value of $9,063.60 and an ultimate completion date of May 5, 2025. This non-set-aside, competitively awarded contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December...
- AmerisourceBergen Drug Corp was awarded a delivery order on September 12, 2025, for the supply of HUMIRA (adalimumab) CF Pen 40 mg/0.4 mL, a biologic pharmaceutical used to treat autoimmune conditions. This competitively awarded, non-set-aside delivery order carries a ceiling value of $11,239.33 under a firm fixed-price arrangement, with an ultimate completion date of September 15, 2025. The contract is funded through the Defense Logistics Agency's Medical Supply Chain, a defense-aligned federal...
- This is a $22,165.92 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS medication. The contract has an ultimate completion date of July 30, 2024 and is not set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL with a ceiling value of $1,185.69. This is a firm fixed price delivery order under a non-set-aside competitive procurement. The contract is set to be completed by August 26, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on August 7, 2025, for HUMIRA (CF) Pen 40 mg/0.4 mL pharmaceutical supplies, with a ceiling value of $9,205.12 and an ultimate completion date of August 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The award represents a small-value transaction typical of...
- The Defense Logistics Agency awarded a $43,110.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, with final delivery required by July 15, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location. This delivery order is issued...